These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 7678053)

  • 1. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A.
    Bongarzone I; Monzini N; Borrello MG; Carcano C; Ferraresi G; Arighi E; Mondellini P; Della Porta G; Pierotti MA
    Mol Cell Biol; 1993 Jan; 13(1):358-66. PubMed ID: 7678053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas.
    Bongarzone I; Butti MG; Coronelli S; Borrello MG; Santoro M; Mondellini P; Pilotti S; Fusco A; Della Porta G; Pierotti MA
    Cancer Res; 1994 Jun; 54(11):2979-85. PubMed ID: 8187085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC.
    Pierotti MA; Santoro M; Jenkins RB; Sozzi G; Bongarzone I; Grieco M; Monzini N; Miozzo M; Herrmann MA; Fusco A
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1616-20. PubMed ID: 1542652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A t(10;17) translocation creates the RET/PTC2 chimeric transforming sequence in papillary thyroid carcinoma.
    Sozzi G; Bongarzone I; Miozzo M; Borrello MG; Blutti MG; Pilotti S; Della Porta G; Pierotti MA
    Genes Chromosomes Cancer; 1994 Apr; 9(4):244-50. PubMed ID: 7519046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
    Santoro M; Dathan NA; Berlingieri MT; Bongarzone I; Paulin C; Grieco M; Pierotti MA; Vecchio G; Fusco A
    Oncogene; 1994 Feb; 9(2):509-16. PubMed ID: 8290261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
    Lanzi C; Borrello MG; Bongarzone I; Migliazza A; Fusco A; Grieco M; Santoro M; Gambetta RA; Zunino F; Della Porta G
    Oncogene; 1992 Nov; 7(11):2189-94. PubMed ID: 1437145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H4(D10S170), a gene frequently rearranged with RET in papillary thyroid carcinomas: functional characterization.
    Celetti A; Cerrato A; Merolla F; Vitagliano D; Vecchio G; Grieco M
    Oncogene; 2004 Jan; 23(1):109-21. PubMed ID: 14712216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer.
    Fugazzola L; Pierotti MA; Vigano E; Pacini F; Vorontsova TV; Bongarzone I
    Oncogene; 1996 Sep; 13(5):1093-7. PubMed ID: 8806699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma.
    Smanik PA; Furminger TL; Mazzaferri EL; Jhiang SM
    Hum Mol Genet; 1995 Dec; 4(12):2313-8. PubMed ID: 8634704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma.
    Borrello MG; Alberti L; Arighi E; Bongarzone I; Battistini C; Bardelli A; Pasini B; Piutti C; Rizzetti MG; Mondellini P; Radice MT; Pierotti MA
    Mol Cell Biol; 1996 May; 16(5):2151-63. PubMed ID: 8628282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5.
    Klugbauer S; Demidchik EP; Lengfelder E; Rabes HM
    Cancer Res; 1998 Jan; 58(2):198-203. PubMed ID: 9443391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning of an activated human ret gene with a novel 5' sequence fused by DNA rearrangement.
    Kunieda T; Matsui M; Nomura N; Ishizaki R
    Gene; 1991 Nov; 107(2):323-8. PubMed ID: 1748302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.
    Grieco M; Santoro M; Berlingieri MT; Melillo RM; Donghi R; Bongarzone I; Pierotti MA; Della Porta G; Fusco A; Vecchio G
    Cell; 1990 Feb; 60(4):557-63. PubMed ID: 2406025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo.
    Grieco M; Cerrato A; Santoro M; Fusco A; Melillo RM; Vecchio G
    Oncogene; 1994 Sep; 9(9):2531-5. PubMed ID: 8058316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
    Kim DW; Hwang JH; Suh JM; Kim H; Song JH; Hwang ES; Hwang IY; Park KC; Chung HK; Kim JM; Park J; Hemmings BA; Shong M
    Mol Endocrinol; 2003 Jul; 17(7):1382-94. PubMed ID: 12738763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusion of a novel gene, ELKS, to RET due to translocation t(10;12)(q11;p13) in a papillary thyroid carcinoma.
    Nakata T; Kitamura Y; Shimizu K; Tanaka S; Fujimori M; Yokoyama S; Ito K; Emi M
    Genes Chromosomes Cancer; 1999 Jun; 25(2):97-103. PubMed ID: 10337992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiation-induced thyroid carcinomas in children: high prevalence of RET rearrangement].
    Rabes HM; Klugbauer S
    Verh Dtsch Ges Pathol; 1997; 81():139-44. PubMed ID: 9474864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the promoter region and oligomerization domain of H4 (D10S170), a gene frequently rearranged with the ret proto-oncogene.
    Tong Q; Li Y; Smanik PA; Fithian LJ; Xing S; Mazzaferri EL; Jhiang SM
    Oncogene; 1995 May; 10(9):1781-7. PubMed ID: 7753554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of childhood papillary thyroid carcinomas after irradiation: high prevalence of RET rearrangement.
    Rabes HM; Klugbauer S
    Recent Results Cancer Res; 1998; 154():248-64. PubMed ID: 10027005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RET rearrangements in radiation-induced papillary thyroid carcinomas: high prevalence of topoisomerase I sites at breakpoints and microhomology-mediated end joining in ELE1 and RET chimeric genes.
    Klugbauer S; Pfeiffer P; Gassenhuber H; Beimfohr C; Rabes HM
    Genomics; 2001 Apr; 73(2):149-60. PubMed ID: 11318605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.